Eurofins Medigenomix / MWG Biotech sequence Wacker Chemie AG’s bacterial protein production strain
About Wacker Biotech W
acker Biotech GmbH is an experienced full-service contract manufacturer of biopharmaceuticals derived from microbial systems. Its portfolio ranges from services in molecular biology, analytical and process development, through GMP-compliant production of clinical test material and drug substance for commercial market supply. Above all, Wacker Biotech offers proprietary technologies that satisfy market needs for cost-efficient and high-quality production. Two examples are its E. coli-based secretion system and the high-cell-density fermentation technology. Jena-based Wacker Biotech is a wholly-owned WACKER subsidiary, operating since early 2005 as the direct successor of ProThera GmbH. For further information please visit the corporate website at: http://www.wacker.com/biologics.
About Eurofins Medigenomix
Eurofins Medigenomix GmbH, located in Martinsried, Germany is an innovative bioanalytical company, specialized in services for DNA analysis. The business unit for DNA sequencing and molecular biology applications is well known as outsourcing partner for the biopharmaceutical industry and academic institutions, the unit for Applied Genetics is a leading provider for DNA forensics, paternity testing in humans and animals and authenticity testing in food. A special strength of Medigenomix' team is the extensive experience in purifying and handling DNA samples from different origin for various applications in DNA analysis. For further information, please visit the corporate website at: www.medigenomix.com.
Eurofins Genomics GmbH
MWG Biotech AG, headquartered in Ebersberg, Germany, is an international provider of DNA sequencing services, DNA/siRNA synthesis products, gene synthesis and bioinformatic services for academic and industrial research.
With production sites in Germany, the US, and India the company’s strength is its strong customer orientation, fast service and high quality products including a series of advanced oligonucleotide and siRNA design tools. For further information, please visit our website www.mwg-biotech.com